In TUXEDO-2, ticagrelor failed to meet the bar for noninferiority, with most outcomes hinting at an advantage for prasugrel.

CHICAGO -- For prolonged antithrombotic treatment after percutaneous coronary intervention (PCI), clopidogrel monotherapy was more effective and at least as safe as aspirin monotherapy in a high-risk ...

The high incidence and mortality rates of cardiovascular and cerebrovascular diseases make them a significant global health challenge. Antiplatelet drugs play a central role in the prevention and ...

A commonly prescribed drug could be more effective than aspirin for long-term heart disease prevention. Analysis of nearly 29,000 patients with coronary artery disease (CAD) suggests the blood thinner ...

Before this Saturday’s enormous nationwide No Kings protests, Leah Greenberg, a founder of Indivisible, one of the groups behind the demonstrations, worried that too many people had lost faith in ...

Background: Variability in responses to clopidogrel and aspirin therapy for coronary artery disease has driven interest in pharmacogenomics. This study investigates the role of genetic variants in ...

People at risk of a cardiac event after a percutaneous coronary intervention (PCI) stent procedure who received long-term antiplatelet therapy with clopidogrel were 29% less likely to die than those ...

People at high risk for recurrent cardiac events following percutaneous coronary intervention (PCI), a procedure to open blocked arteries, experienced significantly better outcomes with clopidogrel ...

It isn’t known for sure whether it’s safe to take clopidogrel during pregnancy. The drug’s clinical trials didn’t include people who were pregnant or breastfeeding. In animal studies, there was also ...

Patients with acute ischaemic stroke or transient ischaemic attack (TIA) are less likely to have secondary vascular events when their clinicians test them for genetic variants conferring resistance to ...